. 2017 Mar 6;8(20):32608–32617. doi: 10.18632/oncotarget.15940

Table 2. II Round JAK2^V617F mutation burden and summary statistics (minimum, maximum, calculation of median, coefficient of variation) of results obtained by the ten participating laboratories with ipsogen JAK2 MutaQuant kit.

Sample	Expected JAK2^V617FAB (%)	Min.	Median	Max	CV (Coefficient of Variation)
DNA G	0	0.002	0.008234	0.02	0.73
DNA E	0.1	0.03	0.09874	0.17	0.42
DNA C	1	0.39	0.8471	1.12	0.24
DNA B	5	2.38	3.643	4.66	0.18
DNA F	10	6.04	8.794	17.65	0.38
DNA H	20	13.12	15.2	19.35	0.11
DNA D	50	30.54	42.62	46.76	0.12
DNA A	100	99.76	99.92	99.97	0.0005

The expected JAK2^V617F mutation burden of the eight DNA samples was 0, 0.1, 1, 10, 20, 50 and 100%.

Table 2. II Round JAK2V617F mutation burden and summary statistics (minimum, maximum, calculation of median, coefficient of variation) of results obtained by the ten participating laboratories with ipsogen JAK2 MutaQuant kit.